Jasper Therapeutics Stock Analysis
| JSPRW Stock | USD 0.20 0.02 9.09% |
Jasper Therapeutics is overvalued with Real Value of 0.13 and Hype Value of 0.2. The main objective of Jasper Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Jasper Therapeutics is worth, separate from its market price. There are two main types of Jasper Therapeutics' stock analysis: fundamental analysis and technical analysis.
The Jasper Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Jasper Therapeutics is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Jasper Stock trading window is adjusted to America/New York timezone.
Jasper |
Jasper Stock Analysis Notes
The company recorded a loss per share of 3.84. Jasper Therapeutics had not issued any dividends in recent years. Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. Jasper Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To learn more about Jasper Therapeutics call Ronald Martell at 650 549 1400 or check out https://www.jaspertherapeutics.com/.Jasper Therapeutics Investment Alerts
| Jasper Therapeutics is way too risky over 90 days horizon | |
| Jasper Therapeutics has some characteristics of a very speculative penny stock | |
| Jasper Therapeutics appears to be risky and price may revert if volatility continues | |
| Jasper Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (64.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Jasper Therapeutics has accumulated about 16.76 M in cash with (52.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Jasper Therapeutics has a frail financial position based on the latest SEC disclosures |
Jasper Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.68) | (0.71) | |
| Return On Capital Employed | (0.83) | (0.88) | |
| Return On Assets | (0.68) | (0.71) | |
| Return On Equity | (0.82) | (0.78) |
Management Efficiency
The company has return on total asset (ROA) of (0.4092) % which means that it has lost $0.4092 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7146) %, meaning that it generated substantial loss on money invested by shareholders. Jasper Therapeutics' management efficiency ratios could be used to measure how well Jasper Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.71 in 2024. Return On Capital Employed is likely to drop to -0.88 in 2024. Other Current Assets is likely to climb to about 1.9 M in 2024, whereas Total Assets are likely to drop slightly above 63.2 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 7.51 | 7.89 | |
| Tangible Book Value Per Share | 7.51 | 7.89 | |
| Enterprise Value Over EBITDA | 0.03 | 0.03 | |
| Price Book Value Ratio | 1.05 | 1.10 | |
| Enterprise Value Multiple | 0.03 | 0.03 | |
| Price Fair Value | 1.05 | 1.10 | |
| Enterprise Value | -19.5 M | -18.5 M |
The strategic initiatives led by Jasper Therapeutics' management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 2.199 | Return On Assets (0.41) | Return On Equity (0.71) |
Technical Drivers
As of the 4th of December, Jasper Therapeutics retains the Standard Deviation of 6.45, risk adjusted performance of 0.0075, and Market Risk Adjusted Performance of 0.0413. Jasper Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Jasper Therapeutics market risk adjusted performance and treynor ratio to decide if Jasper Therapeutics is priced fairly, providing market reflects its last-minute price of 0.2 per share. As Jasper Therapeutics appears to be a penny stock we also urge to confirm its jensen alpha numbers.Jasper Therapeutics Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Jasper Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Jasper Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Jasper Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Jasper Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Jasper Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Jasper Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kapoor Vishal over two months ago Insider Trading | ||
Mahal Jeetinder Singh over two months ago Disposition of tradable shares by Mahal Jeetinder Singh of Jasper Therapeutics subject to Rule 16b-3 | ||
Carlyle Group Inc. over three months ago Acquisition by Carlyle Group Inc. of 3133333 shares of Jasper Therapeutics at 1.5 subject to Rule 16b-3 | ||
Hoffen Howard I over six months ago Acquisition by Hoffen Howard I of 2300000 shares of Jasper Therapeutics subject to Rule 16b-3 | ||
Emster Kurt Von over six months ago Acquisition by Emster Kurt Von of 47000 shares of Jasper Therapeutics at 1.6 subject to Rule 16b-3 | ||
Hoffen Howard I over six months ago Acquisition by Hoffen Howard I of 200000 shares of Jasper Therapeutics subject to Rule 16b-3 |
Jasper Therapeutics Predictive Daily Indicators
Jasper Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Jasper Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Jasper Therapeutics Forecast Models
Jasper Therapeutics' time-series forecasting models are one of many Jasper Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jasper Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Jasper Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Jasper Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Jasper shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Jasper Therapeutics. By using and applying Jasper Stock analysis, traders can create a robust methodology for identifying Jasper entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Jasper Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.